Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03716128 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Diagnosis of Renal Osteodystrophy in Patients With Reduced Renal Function

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion dates: Oct 2025 to Oct 2027v4
  2. Primary and study completion dates: Oct 2020 to Oct 2025v3
  3. Eligibility criteria shortened, about 4 wordsv2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The aim of the study is to 1. To describe the bone morphology in patients with reduced renal function and high or low parathyroid hormone (PTH) respectively. 2. To investigate if the non-invasive method 18-Fluoride Positron Emission Tomography (18F-PET) can describe the bone turnover and reflect the bone histomorphologic changes 3. To investigate if non-oxidized PTH reflects bone turnover
Trial Details
NCT Number NCT03716128
Lead Sponsor Ditte Hansen
Collaborators: University of Copenhagen, Universiteit Antwerpen
Conditions
(from sponsor)		 Renal Osteodystrophy
Related terms Chronic Kidney Disease-Mineral and Bone Disorder
Enrollment 40 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov